Clinical Trials Directory

Trials / Conditions / Fetal Growth Restriction

Fetal Growth Restriction

40 registered clinical trials studyying Fetal Growth Restriction11 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRelationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR
NCT07190157
Izmir City Hospital
Not Yet RecruitingAI-POCUS for Maternal and Neonatal Health in Ethiopia
NCT07171086
Tsinghua UniversityPhase 4
RecruitingMaternal Left Lateral Position in Fetal Growth Restriction
NCT06919692
University of Colorado, DenverN/A
RecruitingThe Combined First Trimester Screening
NCT07015203
Institute of Health Information and Statistics of the Czech Republic
RecruitingStudy of Placental Vascularization Using Contrast Ultrasound
NCT06497959
Central Hospital, Nancy, FrancePhase 3
Not Yet RecruitingPregnancy in GUCH Patients
NCT06574386
Fondazione Policlinico Universitario Agostino Gemelli IRCCSN/A
RecruitingUSCOM in Newly Diagnosed FGR Cases
NCT06343051
Icahn School of Medicine at Mount Sinai
RecruitingProstaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN)
NCT05674487
University Hospital, BordeauxN/A
Active Not RecruitingRole of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning
NCT06372938
Ankara Etlik City Hospital
RecruitingL-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NCT05934318
Liverpool School of Tropical MedicineN/A
RecruitingSpeckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
NCT05423665
University Hospital, Ghent
CompletedEvaluation of HALP Score in Distinction Between FGR and SGA
NCT05814198
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
UnknownCOmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR: COSMOS Study
NCT05034861
Institute of Mother and Child, Warsaw, PolandN/A
UnknownSpeckle Tracking Echocardiography in Infants, Prenatally and Postnatally
NCT05601375
Erasmus Medical Center
WithdrawnTransplacental Aspirin Therapy for Early Onset Fetal Growth Restriction
NCT04557475
Johns Hopkins UniversityPhase 3
CompletedDeveloping and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
NCT05059093
Deepecho
UnknownEvaluation of the Safety and Performance of Centaflow
NCT04438668
CentaflowN/A
UnknownMetals and in Fetal Growth Restriction
NCT04394611
Cengiz Gokcek Women's and Children's Hospital
CompletedExpanded NIPT for Pregnancy Complications
NCT04311749
University of California, San Francisco
TerminatedSleep Apnea and Fetal Growth Restriction
NCT04084990
Washington University School of MedicinePhase 3
UnknownGut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
NCT04399434
Second Affiliated Hospital of Wenzhou Medical University
UnknownLow-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies
NCT04051567
Ministry of Science and Technology of the People´s Republic of ChinaPhase 4
UnknownFetal Distribution of Feto-placental Blood Flow Related to Placental Nutrient Transport and Maternal Food Inta
NCT04215107
Guttorm HaugenN/A
RecruitingInvestigating the Structured Use of Ultrasound Scanning for Fetal Growth
NCT03662178
Oxford University Hospitals NHS Trust
UnknownSildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
NCT03230162
Ain Shams UniversityPhase 3
UnknownSocial Deprivation and Pregnancy
NCT03121196
University Hospital, Clermont-Ferrand
UnknownSildenafil Citrate for Treatment of Growth-restricted Fetuses
NCT03177824
Ain Shams UniversityPhase 3
CompletedTiming of Delivery in Fetal Growth Restriction of Uncomplicated Women
NCT03046355
The University of Texas Health Science Center, HoustonN/A
CompletedPrediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening
NCT03067298
Emmanuel Bujold
CompletedFetal 3D Study (Fetal Body Composition and Volumes Study)
NCT03266198
Katherine Grantz
UnknownAntiphospholipid Antibodies and Fetal Growth Restriction
NCT01538134
Saint Thomas Hospital, Panama
CompletedPre-Eclampsia And Growth Restriction: a Longitudinal Study
NCT02379832
CHU de Quebec-Universite Laval
TerminatedThe Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)
NCT02277132
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2 / Phase 3
CompletedFirst-trimester Prediction of Preeclampsia
NCT02189148
CHU de Quebec-Universite Laval
CompletedA Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings
NCT01990625
NICHD Global Network for Women's and Children's HealthN/A
CompletedA Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community
NCT01741051
Simon Fraser UniversityN/A
UnknownPrediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control St
NCT01981824
Ain Shams Maternity Hospital
CompletedFirst Trimester Prediction of Preeclampsia and Fetal Growth Restriction
NCT02379494
Fetal Medicine Foundation
CompletedThe NICHD Fetal Growth Study: Twin Gestations
NCT01369940
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CompletedDose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnanc
NCT01068795
HaEmek Medical Center, IsraelN/A